Biotech Co. To Pay $4M To End Presentation Hype Suit

By Bill Wichert (April 15, 2022, 3:40 PM EDT) -- A biopharmaceutical company acquired by Gilead Sciences will pay $4 million to resolve class claims in New Jersey federal court alleging it misled investors into expecting that new drug results would be presented at conferences of the American Society of Clinical Oncology, according to a motion seeking preliminary approval of the deal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!